Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Insulin resistance is a critical process in the initiation and progression of diabetic nephropathy (DN). Alprostadil (Prostaglandin E1, PGE1) had protective effects on renal function. However, it is unknown whether PGE1 inhibited insulin resistance in renal tubule epithelial cells via autophagy, which plays a protective role in DN against insulin resistance. Insulin resistance was induced by palmitic acid (PA) in human HK-2 cells, shown as the decrease of insulin-stimulated AKT phosphorylation, glucose transporter-4 (GLUT4), glucose uptake and enhanced phosphorylation of insulin receptor substrate 1(IRS-1) at site serine 307 (pIRS-1ser307) and downregulated expression of IRS-1. Along with less abundance of p62, autophagy markers LC3B and Beclin-1 significantly increased in HK-2 cells exposed to PA. Such abnormal changes were significantly reversed by PGE1, which mimicked the role of autophagy gene 7 small interfering RNA (ATG7 siRNA). Furthermore, PGE1 promoted the protein expression of autophagy-related fibroblast growth factor-21 (FGF21), which alleviated insulin resistance. Results from western blotting and immunohistochemistry indicated that PGE1 remarkably restored autophagy, insulin resistance and the FGF21 expression in rat kidney of type 2 diabetes mellitus (T2DM). Collectively, we demonstrated the potential protection of PGE1 on insulin resistance in renal tubules via autophagy-dependent FGF21 pathway in preventing the progression of DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Kim, K. H., Jeong, Y. T., Oh, H., Kim, S. H., Cho, J. M., Kim, Y.-N., Kim, S. S., Kim, D. H., Hur, K. Y., Kim, H. K., et al. (2013) · Nature Medicine · doi:10.1038/nm.3014 · Cited by 774
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Boden, G. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-39781 · Cited by 348
Research works printed but not linked: 47
- Gnudi, L., Coward, R. J. & Long, D. A. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms. Trends Endocrinol Metab 27, 820–830, https://doi.org/10.1016/j.tem.2016.07.002 (2016). · DOI · Paper page
- Nerpin, E. et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 31, 1550–1555, https://doi.org/10.2337/dc08-0369 (2008). · DOI
- Parvanova, A. I. et al. Insulin Resistance and Microalbuminuria: A Cross-Sectional, Case-Control Study of 158 Patients With Type 2 Diabetes and Different Degrees of Urinary Albumin Excretion. Diabetes 55, 1456–1462, https://doi.org/10.2337/db05-1484 (2006). · DOI · Paper page
- Kim, Y. et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes research and clinical practice 52, 145–152 (2001). · DOI
- Sarafidis, P. A. & Ruilope, L. M. Insulin resistance, microalbuminuria, and chronic kidney disease. Current hypertension reports 10, 249 (2008). · DOI
- Mizushima, N. Autophagy: process and function. Genes Dev 21, 2861–2873, https://doi.org/10.1101/gad.1599207 (2007). · DOI · Paper page
- Xu, D. et al. Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes. Acta Pharmacol Sin 35, 1215–1225, https://doi.org/10.1038/aps.2014.39 (2014). · DOI
- Sailaja Devi, M. M. & Das, U. N. Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 74, 39–60, https://doi.org/10.1016/j.plefa.2005.09.003 (2006). · DOI
- Bevegård, S. & Orö, L. Effect of prostaglandin E1 on forearm blood flow. Scandinavian journal of clinical and laboratory investigation 23, 347–353 (1969). · doi:10.3109/00365516909081700
- Zhao, L. Lu, J. Wang, C. Zhao, W. Qing, E. Ma, J. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting. J Cardiothorac Vasc Anesth 27, 208–1211, https://doi.org/10.1053/j.jvca.2013.07.001 (2013). · doi:10.1053/j.jvca.2013.07.001
- Ninomiya, Y. & Arakawa, M. Renal effects of prostaglandin E1 in type 2 (non-insulin-dependent) diabetic patients with subclinical nephropathy. Diabetes Research 10, 129–134 (1989).
- Okada, S. et al. Effect of prostaglandin E1 on the renin-aldosterone system in patients with diabetic nephropathy. Journal of International Medical Research 21, 126 (1993). · doi:10.1177/030006059302100302
- Sears, B. & Perry, M. The role of fatty acids in insulin resistance. Lipids Health Dis 14, 121, https://doi.org/10.1186/s12944-015-0123-1 (2015). · DOI · Paper page
- Khan, M. J. et al. Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells. J Biol Chem 287, 21110–21120, https://doi.org/10.1074/jbc.M111.319129 (2012). · DOI · Paper page
- Xin, W. et al. Acetyl-CoA carboxylase 2 suppression rescues human proximal tubular cells from palmitic acid induced lipotoxicity via autophagy. Biochem Biophys Res Commun 463, 364–369, https://doi.org/10.1016/j.bbrc.2015.05.070 (2015). · DOI
- Zhu, S. et al. Inhibition of Kupffer Cell Autophagy Abrogates Nanoparticle-Induced LiverInjury. Adv Healthc Mater 6, https://doi.org/10.1002/adhm.201601252 (2017). · DOI
- Wei, Y. M. et al. Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 31, 925–937, https://doi.org/10.1159/000350111 (2013). · DOI · Paper page
- Malik, R. A. et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. The Lancet 352, 1978–1981, https://doi.org/10.1016/s0140-6736(98)02478-7 (1998). · DOI · Paper page
- Bilous, R. et al. Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in DiabetesThree Randomized Trials. Annals of internal medicine 151, 11–20 (2009). · DOI · Paper page
- Vargas, A. V., Krishnamurthi, V., Masih, R., Robinson, A. V. & Schulak, J. A. Prostaglandin E1 attenuation of ischemic renal reperfusion injury in the rat. Journal of the American College of Surgeons 180, 713–717 (1995).
- Schneider, A. et al. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: Possible role of TGFβ. Kidney international 50, 190–199 (1996). · DOI
- Sun, D., Liu, C. X., Ma, Y. Y. & Zhang, L. Protective effect of prostaglandin E1 on renal microvascular injury in rats of acute aristolochic acid nephropathy. Ren Fail 33, 225–232, https://doi.org/10.3109/0886022X.2010.541586 (2011). · DOI
- Boden, G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 37, 635–646, viii-ix, https://doi.org/10.1016/j.ecl.2008.06.007 (2008). · DOI · Paper page
- Okumura, T., Kanemaki, T. & Kitade, H. Stimulation of glucose incorporation into glycogen by E-series prostaglandins in cultured rat hepatocytes. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1176, 137–142 (1993). · DOI
- Yamahara, K. et al. The role of autophagy in the pathogenesis of diabetic nephropathy. J Diabetes Res 2013, 193757, https://doi.org/10.1155/2013/193757 (2013). · DOI · Paper page
- Niso-Santano, M. et al. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy 11, 575–577, https://doi.org/10.1080/15548627.2015.1017222 (2015). · doi:10.1080/15548627.2015.1017222
- Fang, Y., Zhang, H., Zhong, Y. & Ding, X. Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury. Oncotarget 7, 54317 (2016). · DOI
- Zhao, X. et al. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells. Int J Mol Med 35, 684–692, https://doi.org/10.3892/ijmm.2014.2052 (2015). · DOI · Paper page
- Zhang, N., Cao, M. M., Liu, H., Xie, G. Y. & Li, Y. B. Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes. J Physiol Biochem 71, 319–327, https://doi.org/10.1007/s13105-015-0384-1 (2015). · DOI
- Shi, L. et al. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1alpha-Sirt3 signaling pathway. Endocrine 50, 378–389, https://doi.org/10.1007/s12020-015-0599-5 (2015). · DOI
- Kimura, T. et al. Autophagy protects kidney proximal tubule epithelial cells from mitochondrial metabolic stress. Autophagy 9, 1876–1886, https://doi.org/10.4161/auto.25418 (2013). · DOI · Paper page
- Yoshizaki, T. Autophagy in Insulin Resistance. Anti-Aging Medicine 9, 180–184 (2012).
- Li, K. et al. The effects of fibroblast growth factor-21 knockdown and over-expression on its signaling pathway and glucose-lipid metabolism in vitro. Mol Cell Endocrinol 348, 21–26, https://doi.org/10.1016/j.mce.2011.07.026 (2012). · DOI
- Kim, H. W. et al. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice. Endocrinology 154, 3366–3376, https://doi.org/10.1210/en.2012-2276 (2013). · DOI
- Zhang, C. et al. Attenuation of hyperlipidemia-and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation. PloS one 8, e82275 (2013). · DOI · Paper page
- Brooks, N. E. et al. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and beta-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice. Growth Horm IGF Res 30–31, 22–30, https://doi.org/10.1016/j.ghir.2016.08.003 (2016). · DOI
- Wang, H., Deng, J. L., Yue, J., Li, J. & Hou, Y. B. Prostaglandin E1 for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev, CD006872, https://doi.org/10.1002/14651858.CD006872.pub2 (2010). · DOI
- Luo, C. et al. Therapeutic effect of alprostadil in diabetic nephropathy: possible roles of angiopoietin-2 and IL-18. Cell Physiol Biochem 34, 916–928, https://doi.org/10.1159/000366309 (2014). · DOI
- Lee, N. et al. Effect of misoprostol (PGE1) on glucose metabolism in type‐2‐diabetic and control subjects. Diabetes, Obesity and Metabolism 4, 195–200 (2002). · DOI
- Jocks, T. et al. Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury. Journal of the American Society of Nephrology 7, 897–905 (1996). · DOI
- Nakayama, Y. et al. Long-term observation of renal function on combination therapy with prostaglandin and angiotensin-converting enzyme inhibitor for chronic kidney disease. Clinical nephrology 69, 402–407 (2008). · doi:10.5414/cnp69402
- Mahmoud, I. M., Hussein Ael, A., Sarhan, M. E., Awad, A. A. & El Desoky, I. Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury. Nephron Physiol 105, p57–65, https://doi.org/10.1159/000100425 (2007). · DOI
- Reynolds, A. et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. Rna-a Publication of the Rna Society 12, 988–993 (2006). · DOI · Paper page
- Ji, K. et al. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1alpha pathway. Free Radic Biol Med 84, 161–170, https://doi.org/10.1016/j.freeradbiomed.2015.03.020 (2015). · DOI
- Choi, S. E. et al. Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology 150, 126–134, https://doi.org/10.1210/en.2008-0483 (2009). · DOI · Paper page
- Reed, M. J. et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49, 1390–1394, https://doi.org/10.1053/meta.2000.17721 (2000). · DOI · Paper page
- Okita, K. et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocrine journal 60, 283–290 (2013). · DOI
Cited by
Miller, M. E., Hamann, M., & Kroon, F. J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240792 · Cited by 657
Towards understanding two-level-systems in amorphous solids: insights from quantum circuits
Müller, C., Cole, J. H., & Lisenfeld, J. (2019) · Reports on Progress in Physics · doi:10.1088/1361-6633/ab3a7e · Cited by 508
Cardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
Hardware Implementation of Neuromorphic Computing Using Large‐Scale Memristor Crossbar Arrays
Li, Y., & Ang, K.-W. (2021) · Advanced Intelligent Systems · doi:10.1002/aisy.202000137 · Cited by 220
A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors
Sen, T., & Heerspink, H. J. L. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.016 · Cited by 161
Metadata
- Authors
- Wei, W., An, X.-R., Jin, S.-J., Li, X.-X., & Xu, M.
- Venue
- Scientific Reports
- Published
- 2018-01-08
- Volume
- 8
- Issue
- 1
- Pages
- 9-9
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2782491382
- Cited by
- 117
- References
- 11
- FWCI
- 17.10
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy. https://app.cochat.ai/papers/10.1038/s41598-017-18427-2
- The paper
- Wei, W., An, X.-R., Jin, S.-J., Li, X.-X., & Xu, M. (2018). Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy. Scientific Reports. https://doi.org/10.1038/s41598-017-18427-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.